Patents Assigned to Edwards Lifesciences Corporations
  • Patent number: 11547561
    Abstract: The methods and devices disclosed herein promote temporal control of balloon inflation patterns. The devices include a covering for a portion of the balloon that compresses the balloon portion during the inflation process. This enables the distal portion of a balloon to be inflated prior to the proximal portion of a balloon, creating a tapered shape at lower inflation pressures. This is especially useful during transvascular implantation procedures, as it prevents dislodgement of an implant mounted on the balloon. As inflation continues, pressure exerted on the balloon by the covering is overcome such that the proximal region of the balloon inflates, forming a shape with generally straighter sides than the tapered shape, thereby expanding the cardiovascular device.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: January 10, 2023
    Assignee: Edwards Lifesciences Corporation
    Inventors: Yidong M. Zhu, Pu Zhou, Erik Bulman, Baigui Bian
  • Patent number: 11547564
    Abstract: A valve repair device for repairing a native valve of a patient includes a pair of paddles and a pair of gripping members. The pair of paddles are movable between an open position and a closed position. Each paddle comprises a metal loop that is moveable from a compressed condition where each metal loop has a first width to an expanded condition where each loop has a second width that is greater than the first width. The pair of gripping members are configured to attach to the native valve of the patient.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: January 10, 2023
    Assignee: Edwards Lifesciences Corporation
    Inventors: Asher L. Metchik, Sergio Delgado, Alexander J. Siegel, Eric Robert Dixon, Lauren R. Freschauf, Matthew T. Winston, Gregory Scott Tyler, II
  • Patent number: 11547544
    Abstract: Disclosed herein is a storage container for an expandable prosthetic heart valve that crimps the valve upon opening the container and removal of the valve from the container. The container includes a housing sized to receive the heart valve in its expanded configuration and a crimping mechanism. The crimping mechanism is incorporated into the container and engages the heart valve so as to operably convert the heart valve from its expanded configuration to its smaller crimped configuration upon opening the container and removing the valve.
    Type: Grant
    Filed: February 12, 2021
    Date of Patent: January 10, 2023
    Assignee: Edwards Lifesciences Corporation
    Inventors: Noam Nir, Carmel Peleg, Tomer Saar, Alexander Barash, David Maimon
  • Patent number: 11540918
    Abstract: Prosthetic heart valves and methods of implantation thereof are disclosed herein. In embodiments, a prosthetic heart valve includes a self-expandable frame configured to support of valve member and comprising a plurality of interconnected strut members forming a mesh structure. An inflow end and outflow end portions of the mesh structure respectively define an inflow terminal end and an outflow terminal end of the frame. A portion of the frame tapers inwardly from the inflow terminal end to form a reduced diameter section. In implementations, the frame increases in diameter from the reduced diameter section to an intermediate section. In implementations, the valve member is secured to the frame at the inflow end portion. In implementations, the frame further comprises a plurality of retaining arms that extend from the outflow terminal end and are configured to engage with a valve retaining mechanism of a delivery apparatus.
    Type: Grant
    Filed: November 23, 2021
    Date of Patent: January 3, 2023
    Assignee: Edwards Lifesciences Corporation
    Inventors: David Alon, Netanel Benichou, Oded Meiri
  • Patent number: 11540835
    Abstract: The present teachings provide methods for resizing, reducing, and/or closing an atrial appendage. A delivery catheter is percutaneously advanced to the atrial appendage. At least two tissue anchors are implanted in tissue of the heart. Both tissue anchors are pulled together so that the atrial appendage is resized, reduced, and/or closed. This closure method and system could be used alone in closing the atrial appendage. This closure method and system could also be used in addition to other treatment mechanisms.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: January 3, 2023
    Assignee: Edwards Lifesciences Corporation
    Inventors: Adam Groothuis, Steven D. Cahalane
  • Patent number: 11529058
    Abstract: A stretch-measurement probe includes an elongate outer sleeve, expansion feature associated with a distal portion of the outer sleeve, and an elongate inner rod disposed at least partially within the outer sleeve. The expansion feature is configured to allow a longitudinal distance between a proximal end of the outer sleeve and the distal end of the outer sleeve to be varied.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: December 20, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Gregory Bak-Boychuk, Stanton J. Rowe
  • Patent number: 11529233
    Abstract: Methods and devices for the treatment of cardiac valve dysfunction through the placement of lines and anchors. The lines and anchors can form artificial chordae between valve leaflets and the ventricular wall or papillary muscles or connect the two valve leaflets together. The methods and devices offer a mechanism for performing this technique with the heart still beating, and allows for the placement of multiple lines with a single device.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: December 20, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Yaron Keidar, Adam J. Yestrepsky
  • Patent number: 11523901
    Abstract: The present invention relates to devices and methods for improving the function of a defective heart valve, and particularly for reducing regurgitation through an atrioventricular heart valveā€”i.e., the mitral valve or tricuspid valve. For a tricuspid repair, the device includes an anchor deployed in the tissue of the right ventricle, in an orifice opening to the right atrium, or anchored to the tricuspid valve. A flexible anchor rail connects to the anchor and a coaptation element on a catheter rides over the anchor rail. The catheter attaches to the proximal end of the coaptation element, and a locking mechanism fixes the position of the coaptation element relative to the anchor rail. A proximal anchoring feature fixes the proximal end of the coaptation catheter subcutaneously adjacent the subclavian vein. The coaptation element includes an inert covering and helps reduce regurgitation through contact with the valve leaflets.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: December 13, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Vivian Khalil, Erin M. Spinner, Neil S. Zimmerman, Alexander J. Siegel, Son V. Nguyen
  • Patent number: 11523923
    Abstract: Disclosed herein is a method of crimping a prosthetic heart valve using a compact crimping mechanism. The crimping mechanism includes a plurality of jaws configured for coordinated inward movement toward a crimping axis to reduce the size of a crimping iris around a stented valve. A rotating cam wheel acts on the jaws and displaces them inward. An actuation mechanism includes a lead screw, carriage assembly and a linkage to rotate the cam wheel with significant torque.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: December 13, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Tomer Saar, Gregory Rinberg
  • Publication number: 20220387174
    Abstract: Embodiments of a prosthetic valve delivery apparatus are disclosed. The delivery apparatus can include an indicator arm changeable between a first configuration and a second configuration. The second configuration is different from the first configuration in location or shape of the indicator arm. The indicator arm can be configured to remain in the first configuration when a diameter of the prosthetic valve is smaller than a first predetermined size, and change to the second configuration when the diameter of the prosthetic valve is expanded to the first predetermined size.
    Type: Application
    Filed: August 15, 2022
    Publication date: December 8, 2022
    Applicant: Edwards Lifesciences Corporation
    Inventors: Elazar Levi Schwarcz, Oren Cohen, Ofir Witzman
  • Publication number: 20220387175
    Abstract: A prosthetic heart valve comprises an annular frame that is radially compressible and expandable between a radially compressed state and a radially expanded state, wherein the frame elongates in an axial direction when radially compressed from the radially expanded state to the radially compressed state. Leaflets are coupled to the frame such that when the frame is in the radially expanded state, the leaflets have slack in an axial direction, wherein when the frame is radially compressed to a partially radially compressed state between the radially expanded state and the radially compressed state, the leaflets are in a relaxed state, and wherein when the frame is in the radially compressed state, the leaflets are stretched in the axial direction.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 8, 2022
    Applicant: Edwards Lifesciences Corporation
    Inventors: Ziv Yohanan, Noam Nir, Elena Sherman
  • Patent number: 11517426
    Abstract: The present disclosure concerns embodiments of implantable prosthetic devices, and in particular, implantable prosthetic valves, and methods for making such devices. In one aspect, a prosthetic device includes encapsulating layers that extend over a fabric layer and secure the fabric layer to another component of the device. In particular embodiments, the prosthetic device comprises a prosthetic heart valve, and can be configured to be implanted in any of the native heart valves. In addition, the prosthetic heart valve can be, for example, a transcatheter heart valve, a surgical heart valve, or a minimally-invasive heart valve.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: December 6, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Celeste C. Bonyuet, Andrew L. Walls, John F. Migliazza, Itai Pelled
  • Patent number: 11517428
    Abstract: Artificial heart valves, their manufacture, and methods of use are described. Generally, artificial heart valves can be deployed to replace or supplement defective heart valves in a patient. These artificial heart valves can comprise a frame with an inner skirt and leaflets. These inner skirt and leaflets can be generated from regenerative tissue to allow integration of the tissue with the body of a patient, while the frame can be generated from bioabsorbable material to allow dissolution of the frame over time. This combination of materials may allow for the artificial valve to grow with a patient and avoid costly and potentially dangerous replacement for patients receiving artificial valves.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: December 6, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Hao Shang, Louis A. Campbell
  • Patent number: 11517435
    Abstract: A prosthetic cardiac valve assembly and method of implanting the same is disclosed. In certain disclosed embodiments, the prosthetic valve assembly is an annuloplasty ring with an attached artificial valve. The prosthetic valve assembly can be secured to native heart tissue by suturing or other suitable method of the annuloplasty ring to the native heart tissue. The prosthetic valve leaflets of the prosthetic valve can also be anchored to the native heart tissue to prevent prolapse. In certain embodiments, the prosthetic valve leaflets are anchored to the native papillary muscles. In still other embodiments, the prosthetic valve assembly contains exactly the number of prosthetic valve leaflets as are in the native valve that the prosthetic valve assembly is configured to replace. With the prosthetic valve assembly properly positioned, it will replace the function of the native valve.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: December 6, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventor: Harvey H. Chen
  • Patent number: 11517427
    Abstract: Systems, dies, and methods are provided for processing pericardial tissue. The method includes positioning a die-cut assembly over the pericardial tissue, the die-cut assembly including a die having a plate, a die pattern, and an opening, the die pattern attached to the plate, the opening formed in the plate to provide access to the pericardial tissue, and measuring a thickness of the tissue through the opening. The die-cut assembly may be mounted for automated vertical movement, and a platen on which the tissue is placed is capable of automated horizontal movement. Different target areas on the tissue can be assessed by measuring the thickness through the die, and when an area is deemed suitable the die pattern cuts a shape therefrom. The system is useful for cutting uniform thickness heart valve leaflets, and can be automated to speed up the process.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: December 6, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Oanh H. Nguyen, Ivan Jankovic, Diana Nguyen-Thien-Nhon, Juan C. Velez, Jon Boomgarden
  • Patent number: 11517718
    Abstract: A delivery apparatus includes a steerable shaft having a pull-wire conduit. A pull wire extends through the pull-wire conduit. The steerable shaft includes one or more layers. A compression-resistance portion is incorporated into at least one of the one or more layers. A cross-section of the compression-resistance portion has an arcuate shape that extends along a portion of a cross-section of the steerable shaft. The compression-resistance portion has a hardness that is greater than a hardness of the one or more layers that the compression-resistance portion is incorporated into.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: December 6, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Matthew T. Winston, Christopher J. Olson, Asher L. Metchik, Tri D. Tran, Alexander J. Siegel
  • Publication number: 20220379094
    Abstract: A delivery sheath includes an outer tubular layer and an initially folded inner tubular layer. When an implant passes therethrough, the outer tubular layer expands and the inner tubular layer unfolds into an expanded lumen diameter. The sheath may also include selectively placed longitudinal support rods that mediate friction between the inner and outer tubular layers to facilitate easy expansion, thereby reducing the push force needed to advance the implant through the sheath's lumen.
    Type: Application
    Filed: August 8, 2022
    Publication date: December 1, 2022
    Applicant: Edwards Lifesciences Corporation
    Inventors: Pu Zhou, Erik Bulman, Timothy A. Geiser, Michael G. Valdez, Yidong M. Zhu, Baigui Bian, Sonny Tran, Richard D. White, Thanh Huy Le, Tung T. Le, Alpana Kiran Gowdar, Yong Gao, David Delon Williams
  • Patent number: 11510794
    Abstract: Disclosed herein is a method of crimping a prosthetic heart valve using a compact crimping mechanism. The crimping mechanism includes a plurality of jaws configured for coordinated inward movement toward a crimping axis to reduce the size of a crimping iris around a stented valve. A rotating cam wheel acts on the jaws and displaces them inward. A number of Cartesian guide elements cooperate with the jaws to distribute forces within the crimping mechanism. The guide elements are located between the crimping jaws and an outer housing and are constrained by the outer housing for movement along lines that are tangential to a circle centered on the crimping axis. The guide elements engage at least some of the crimping jaws while the rest are in meshing engagement so as to move in synch. An actuation mechanism includes a lead screw, carriage assembly and a linkage to rotate the cam wheel with significant torque.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: November 29, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Tomer Saar, Gregory Rinberg
  • Patent number: 11510778
    Abstract: Methods are described herein for delivering a replacement valve to a native valve location. In one method, ventricular anchors of the replacement valve are released and allowed to reverse orientation while positioned in the atrium of a human heart. After reversing orientation, the ventricular anchors extend in a generally proximal direction. The ventricular anchors can then be advanced through the annulus into the ventricle and then moved back toward the atrium to capture native valve leaflets between the main body and the ventricular anchors of the replacement valve. In one modification, the ventricular anchors are allowed to reverse orientation at a level adjacent the annulus. The implantation methods described herein are preferably performed via a transseptal delivery approach or a transapical delivery approach.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: November 29, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: J. Brent Ratz, Glen T. Rabito
  • Patent number: 11510779
    Abstract: Embodiments of the present disclosure provide an introducer device for introducing a medical device into a patient's vasculature. In one embodiment, the introducer device comprises a housing, a distal sheath adapted to be inserted into a patient's vasculature with the housing positioned outside of the patient's vasculature, a hemostatic seal mounted within the housing, and a tube positioned within the housing and movable longitudinally relative to the hemostatic seal between a proximal position and a distal position. In the proximal position, a distal end of the tube is positioned proximal to the hemostatic seal with the hemostatic seal closed. In the distal position, the distal end of the tube extends through the hemostatic seal and permits the medical device to be inserted through the housing and into the patient's vasculature without contacting the hemostatic seal.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: November 29, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Philippe Marchand, David M. Taylor, Robert Milich, David J. Evans, Christopher Chia, Ronaldo C. Cayabyab, Robert Bowes